NEW CLUES TO CHRONIC DISEASES TURN UP IN THE GUT.

This article discusses recent research on the role of the gut microbiome in chronic diseases. One study found that a protein called aryl hydrocarbon receptor (AHR) may play a role in multiple sclerosis (MS). When mice with MS were given gut microbiota from mice lacking AHR, they recovered. This could lead to improved treatments for MS. Another study found a link between the bacterial species Desulfovibrio (DSV) and Parkinson's disease. Worms fed DSV from Parkinson's patients had more protein aggregates and higher mortality rates. Researchers are investigating methods to reduce these strains. Additionally, a study from the Chinese University of Hong Kong found that a daily capsule of live intestinal bacteria was effective in relieving symptoms of long COVID. The treatment, known as SIM01, improved digestive problems, fatigue, difficulty concentrating, memory impairment, and general unwellness in patients. These findings suggest that the gut microbiome may hold potential for treating various ailments. [Extracted from the article]